SCHEMBL7681102

SCHEMBL7681102

COc1cc(Br)c(-n2cc(C#N)cc2N)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 5/20 0.34
CYP3A4 P08684 2/20 0.34
ESRRA P11474 1/20 0.34
ESR2 Q92731 1/20 0.34
CRHR1 P34998 4/20 0.34
KDM4E B2RXH2 3/20 0.32
GBA1 P04062 1/20 0.32
HPGD P15428 1/20 0.32
USP2 O75604 1/20 0.32
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPKAPK2 P49137 1/20 0.31
KDM1A O60341 1/20 0.31
AR P10275 1/20 0.31
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678416 0.69 CRHR1 (0.38) POLBESRRAESR2CRHR1MAPT
SCHEMBL6219170 0.66 CA12 (0.33) POLBL3MBTL1ALDH1A1KDM4EHPGD
SCHEMBL28661191 0.66 ALDH1A1 (0.46) POLBL3MBTL1ALDH1A1CYP3A4CRHR1
SCHEMBL18585500 0.63 MAPT (0.48) POLBL3MBTL1ALDH1A1CYP3A4ESRRA
SCHEMBL7479301 0.63 MAPT (0.57) POLBL3MBTL1ALDH1A1CYP3A4CRHR1
SCHEMBL8822780 0.62 DDR1 (0.32) L3MBTL1CYP3A4MAPT
SCHEMBL202404 0.62 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP1A2CYP2C19KDM1A
SCHEMBL4053444 0.61 ALDH1A1 (0.50) POLBALDH1A1CYP3A4KDM4EGBA1
SCHEMBL15647191 0.61 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EGBA1HPGD
SCHEMBL5787995 0.61 AR (0.44) POLBALDH1A1CYP3A4ESRRAESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed